Ezio Bonvini - Feb 22, 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Stock symbol
MGNX
Transactions as of
Feb 22, 2024
Transactions value $
-$160,252
Form type
4
Date filed
2/26/2024, 04:26 PM
Previous filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +28.1K +34.24% $0.00 110K Feb 22, 2024 Direct F1
transaction MGNX Common Stock Tax liability -$160K -9.37K -8.49% $17.11 101K Feb 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -28.1K -100% $0.00* 0 Feb 22, 2024 Common Stock 28.1K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.